News & Updates

ICD-10 Code for Substance-Induced Psychosis: Quick Reference Guide

By Noah Patel 218 Views
icd-10 code forsubstance-induced psychosis
ICD-10 Code for Substance-Induced Psychosis: Quick Reference Guide

Accurately identifying the ICD-10 code for substance-induced psychosis is essential for clinicians, coders, and billing professionals working in mental health and emergency medicine. This specific diagnosis captures a temporary state of psychosis where hallucinations and delusions are directly caused by the physiological effects of a substance, rather than by an underlying primary psychotic disorder like schizophrenia. Correct application ensures proper patient care tracking, facilitates epidemiological research, and determines reimbursement accuracy, making precision in coding a non-negotiable standard.

Understanding the Clinical Definition

Substance-induced psychosis is characterized by a disturbance in perception and thought that develops during or shortly after intoxication or withdrawal from a psychoactive substance. The diagnostic criteria require that the psychotic symptoms are either caused by the substance itself or occur during withdrawal, and that they are not better explained by a psychotic disorder that is independent of the substance use. Symptoms can include delusions, hallucinations, disorganized speech, and severely disorganized or catatonic behavior, often creating a clinical picture that is indistinguishable from primary psychotic episodes to the untrained observer.

Differentiating from Primary Psychotic Disorders

The distinction between substance-induced and primary psychotic disorders is a core challenge in psychiatric assessment and directly impacts the assigned ICD-10 code. If psychotic symptoms persist beyond the expected duration of intoxication or withdrawal, or if they occur independently in the absence of substance use, the diagnosis may shift to a primary psychotic disorder. Clinicians must conduct thorough interviews, review toxicology screens, and monitor symptom resolution to rule out underlying conditions such as schizophrenia or bipolar disorder with psychotic features before finalizing the code.

ICD-10 Code Specifications and Range

The ICD-10 system categorizes these diagnoses under the chapter for Mental, Behavioral and Neurodevelopmental disorders, specifically within the block due to psychoactive substance use. The coding structure requires a high level of specificity that includes both the substance category and the behavioral manifestation. The following table outlines the primary codes used for substance-induced psychotic disorders:

ICD-10 Code
Description
F1x.5
Substance-induced psychotic disorder, where X represents the specific class of the substance (e.g., F11.5 for opioids, F12.5 for inhalants, F13.5 for sedatives, F14.5 for cocaine, F15.5 for cannabis, F16.5 for hallucinogens, F17.5 for tobacco, and F18.5 for multiple substances).
F19.5
Substance-induced psychotic disorder, unspecified substance.

Code Excludes1 Notes

It is critical to review the Tabular List entries to avoid misassignment. Code F1x.5 includes psychotic disorders due to acute intoxication, psychotic disorders due to withdrawal, and psychotic disorders due to combined intoxication and withdrawal. However, it explicitly excludes chronic psychotic states that are presumed to be substance-induced, which would fall under different categories for persistent mental disorders caused by drugs.

Clinical Assessment and Documentation Requirements

For accurate coding, the medical record must provide clear evidence linking the psychosis to the substance. Documentation should specify the substance involved, the temporal relationship between use and symptom onset, and the clinical course of the psychosis. Providers must state whether the condition is due to intoxication, withdrawal, or both; vague terms like "psychosis NOS" are insufficient. Detailed clinical notes that describe the patient's presentation, timeline, and toxicology findings are the foundation of compliant coding and justify the use of the F1x.5 sequence.

Impact on Patient Management and Prognosis

N

Written by Noah Patel

Noah Patel is a Senior Editor focused on business, technology, and markets. He favors data-backed analysis and plain-language explanations.